Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Dec 8;16(12):e0260902. doi: 10.1371/journal.pone.0260902

Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids

Alessandro Cherubini 1,#, Francesco Rusconi 1,#, Lorenza Lazzari 1,*
Editor: Zoltán Rakonczay Jr2
PMCID: PMC8654213  PMID: 34879096

Abstract

In the last few years, there has been a considerable increase in the use of organoids, which is a new three-dimensional culture technology applied in scientific research. The main reasons for their extensive use are their plasticity and multiple applications, including in regenerative medicine and the screening of new drugs. The aim of this study was to better understand these structures by focusing on the choice of the best housekeeping gene (HKG) to perform accurate molecular analysis on such a heterogeneous system. This feature should not be underestimated because the inappropriate use of a HKG can lead to misleading data and incorrect results, especially when the subject of the study is innovative and not totally explored like organoids. We focused our attention on the newly described human pancreatic organoids (hPOs) and compared 12 well-known HKGs (ACTB, B2M, EF1α, GAPDH, GUSB, HPRT, PPIA, RNA18S, RPL13A TBP, UBC and YWHAZ). Four different statistical algorithms (NormFinder, geNorm, BestKeeper and ΔCt) were applied to estimate the expression stability of each HKG, and RefFinder was used to identify the most suitable genes for RT-qPCR data normalization. Our results showed that the intragroup and intergroup comparisons could influence the best choice of the HKG, making clear that the identification of a stable reference gene for accurate and reproducible RT-qPCR data normalization remains a critical issue. In summary, this is the first report on HKGs in human organoids, and this work provides a strong basis to pave the way for further gene analysis in hPOs.

Introduction

In the last few years, there has been a remarkable increase in the use of organoid technology in scientific research. Organoids are three-dimensional cellular bodies that can be generated from pluripotent stem cells (embryonic or induced) or adult tissue-specific ancestor cells [1]. The main reasons for their considerable use are their plasticity and multiple applications, including as new models to study specific diseases [2], in regenerative medicine [3] and the screening of new drugs [4].

Many types of organs can be recapitulated in various types of organoids, including the gut [5], brain [6], kidney [7] and liver [8]. Human organoids have been widely studied for a variety of purposes. In particular, human pancreatic organoids (hPOs) have been characterized and presented to be a potential source of functional cells for the treatment of type 1 diabetes [9, 10].

For any type of hPO application such as a three-dimensional platform for tissue regeneration, disease modelling, and drug screening, the gene expression of specific tissue-related genes is a crucial requisite to define their identity. To monitor gene expression, RT-qPCR is often the method of choice due to its sensitive and specific detection, potential for high throughput, rapid and accurate quantification, and high degree of potential automation. In order to obtain gene expression results that are not only accurate but also comparable among different experimental setups, conditions, operators and laboratories, normalization of RT-qPCR data should be performed against one or two housekeeping genes (HKGs). These HKGs must display unchanged cellular expression, irrespective of the experimental conditions, and this is fundamental to achieve reliable results [11].

Moreover, the selection of the HKG for normalization of RT-qPCR data should take into account the expression stability of HKGs among different specimens and experimental conditions [11, 12]. This point should not be underestimated because an inappropriate choice of the HKG can lead to misleading data and incorrect results [13, 14], especially when the subject of the study is innovative and not totally explored like organoids. Unfortunately, the importance of selecting appropriate reference genes is not adequately emphasized by researchers; therefore, the validation process and the comparison of molecular biology data remain controversial and open topics.

The aim of this study was to compare 12 well-known HKGs (ACTB, B2M, EF1α, GAPDH, GUSB, HPRT, PPIA, RNA18S, RPL13A TBP, UBC, and YWHAZ; S1 Table), belonging to different functional families, on hPOs at different passages (P0, P2, P5, P7, P10) in order to identify the most stable HKGs suitable for hPO analysis. Finally, we quantified the differential expression of a panel of pancreatic markers to assess the effect of HKG variability on their transcriptional patterns.

This is the first report on HKGs in human organoids, and this work provides a strong basis to pave the way for further gene analysis in hPOs.

Materials and methods

hPO isolation and culture

hPOs were generated starting from adult healthy islet-depleted pancreatic tissue (gently provided by the Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy), after approval of the Institutional Review Board (National Transplant Center accredited facility IT000679), as previously described [9]. All experiments were performed according to the amended Declaration of Helsinki. The use of human specimens was approved by the Ethical Committee of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico n° 1982, 14th January 2020.

Briefly, pancreatic tissue was dissociated by GentleMACS Dissociator (Miltenyi), then the resulting fragments were embedded into Matrigel (Corning, cat. #356231) and cultured in 24-well non-tissue culture microplates (Sarstedt, cat. #83.3922.500) covered by the complete growing medium: AdDMEM/F12 medium (Gibco, cat. #12634–010) supplemented with 10 mM HEPES (Sigma, cat. #H3375), 1X Glutamax (Gibco, cat. #35050061) 1X Penicillin-Streptomycin (Gibco, cat. 15140122), 1X B27 without vitamin A (Gibco, cat. # 12587–010), 1X N2 supplement (Gibco, cat. # 17502048), 1 mM N-acetyl-L-cysteine (Sigma, cat. #A9165), 1 μg/ml recombinant human protein Rspo1 (Peprotech, cat. #120–38), 0.1 μg/ml recombinant human Noggin (Peprotech, cat. #120-10C), 50 ng/ml recombinant human EGF (Peprotech, cat. #AF-100-15), 10 nM human (Leu15)-Gastrin I (Sigma, cat. #G9145), 100 ng/ml recombinant FGF10 (Peprotech, cat. #100–26), 10 mM Nicotinamide (Sigma, cat. #N0636), 10 μM Forskolin (Tocris, cat. #1099), 0.5 μM A83-01 (Tocris, cat. #2939) and 3 μM Prostaglandin E2 (Tocris, cat. #2296). The medium was changed every 3 days, and hPOs were split at a ratio of 1:4 every 7 days.

Flow cytometric analysis

hPOs were collected and washed with fresh AdDMEM/F12 medium supplemented with 10 mM HEPES, 1X Glutamax, 1X Penicillin-Streptomycin and centrifuged for 5 min at 300 x g to remove the Matrigel. Then, the cells were dissociated by trypsinization using Tryple (Life Technologies ref. 12604013) for 15 min to obtain a single-cell suspension. We stained the samples using 1:200 FITC mouse Anti-Human Epithelial Cell Adhesion Molecule (EpCAM; BD, cat. #347197), 1:100 Alexa Fluor® 647 Mouse Anti- SRY-box transcription factor 9 (Sox9; BD, cat. #565493) and 1:2000 FITC-conjugated lectin from Ulex europaeus (UEA1) (Sigma-Aldrich, cat. #L9006). For surface marker analysis (EpCAM and UEA1), the cells were incubated with fluorophore-conjugated antibodies for 20 min in the dark at room temperature (RT) and then washed with PBS. For intracellular marker analysis (SOX9), the cells were fixed with 4% paraformaldehyde (Electron Microscopy Sciences, ref. 15710) for 30 min at RT and permeabilized for 1 h on ice with permeabilization buffer (PBS + 5% NGS (Sigma-Aldrich, cat #NS02L) and 0.1% TRITON X (Eurobio, cat #GAUTTR00-01). Cells were then stained with primary antibody resuspended in permeabilization buffer and prepared for analysis, as described for the extracellular markers. Finally, the samples were analysed in a FACSCanto II cytometer with FACSDiva analysis software (Becton Dickinson).

RNA extraction and qPCR analysis

Total RNA extraction was performed using TRIzol reagent (Ambion, cat. #15596–026), according to the manufacturer’s instructions. Next, its concentration and quality were measured using a NanoDrop ND-100 spectrophotometer (NanoDrop Technologies), and only samples with 260/280 and 260/230 ratios > 1.8 were accepted. cDNA was synthesized starting from 500 ng of the extracted RNA using iScript Advanced cDNA Synthesis Kit for RT-qPCR (BioRad, cat. #1725038), following the manufacturer’s indications. Moreover, to avoid side effects caused by retrotranscription efficiency, we added ERCC RNA Spike-In mix diluted 1:500 to the RNA (Invitrogen, cat. #4456740). The resulting product was diluted 1:10, and 1 μL was used as the template for RT-qPCR. qPCR analysis was completed using SYBR Selected Master Mix (Life Technologies, cat. # 4472908) on a CFX96 thermal cycler (BioRad). All primers used in this study, listed in S2 Table, were designed using Primer 3 software.

Primer efficiency and quality

The efficiency of each pair of primers was tested. Briefly, serial dilutions starting from 100 ng of cDNA (6 dilutions were generated) of cDNA samples were used as templates for qPCR analysis. The standard (STD) function of the CFX Manager™ Software (Biorad, cat. #1845000) was run to generate the linear regression line, and the efficiency of each pair of primers was obtained. To exclude the generation of nonspecific amplicons, qPCR products were run on an 2% agarose gel with dH2O. The products were isolated from the gel using the Wizard SV Gel and PCR Clean-Up System (Promega, cat. #A9282) and were sequenced to underline the specificity of the primers used by Sanger sequencing (S1 File).

Best HKG selection

The selection of the best HKG was carried out by focusing on four different methods: ΔCt method (which values the fluctuation of the ΔCt making a comparison between two or more HKGs) [15], geNorm software (www.genorm.cmgg.be; which calculates the stability of each gene through intragroup differences and mean pairwise variation) [16], NormFinder software (www.moma.dk/normfinder-software; which evaluates gene stability using both intragroup and intergroup changes) [17] and BestKeeper software (www.gene-quantification.de/bestkeeper.html; which ranks the genes in agreement with the standard deviation of their Ct values in correlation with intragroup alterations) [18].

The data were integrated to obtain a final rank, based on the geometric mean, using the RefFinder tool (www.github.com/fulxie/RefFinder).

Statistical analysis

All statistical analyses were performed using Prism7 (GraphPad) on three biological replicates for each experiment. All data passed the Grubb’s test excluding the presence of outliers and then were statistically assessed by the non-parametric one-way analysis of variance (ANOVA) test followed by Bonferroni or Dunnett’s multiple comparisons post-hoc test, as indicated in the figure legends.

Results

hPO characterization

The hPOs showed a cauliflower- or cyst-like structure when they were embedded in Matrigel, and they could be passaged and maintained in culture for at least 10 passages without showing phenotypic changes (Fig 1A). After culturing for 10 days, the cellular composition was characterized. Flow cytometric analysis showed that the majority of the hPO cells (>95%) were positive for EpCAM, thus recapitulating the epithelial exocrine compartment of the initial pancreatic tissue. Focusing on SOX9 and UEA1, well-known markers for ductal and acinar cells, respectively [9, 19, 20], we observed a consistent presence of SOX9-positive cells (71.0% ± 10.0%) and a lower percentage of UEA1-positive cells (19.3% ± 5.0%) (Figs 1B and S1).

Fig 1. Human pancreatic organoid characterization.

Fig 1

(A) Representative bright-field images taken after organoid culture of early (< 2 months) and late (> 2 months) passages for 10 days. Scale bar, 500 μm. (B) Immunophenotypic analysis of hPOs at different passages by evaluation of ductal and acinar markers. Data are expressed as the mean ± standard deviation (n  =  3/group). One-way analysis of variance followed by the Bonferroni post-hoc test for multiple comparisons was used.

Expression profile of candidate HKGs

To determine the most reliable reference genes, 12 widely used HKGs, belonging to different functional classes or pathways, were selected to reduce the probability of including co-regulated genes (S1 Table). Agarose gel electrophoresis of the RT-qPCR products showed that all primer pairs amplified products of the predicted size, without evidence of unspecific amplicons in either the cDNA or negative control reaction (Fig 2A). Moreover, all products showed individual dissociation curves at a temperature higher than 75°C, indicating that they were not primer dimers (Fig 2B). In addition, a standard curve was generated for each HKG using two-fold serial dilution of cDNA. The curves showed that the RT-qPCR efficiency of each primer pair ranged between 95% and 105% (S2 Table), which is in agreement with MIQE guidelines [11]. Considering all samples and setting a Ct cut-off > 35 for weak expression, the 12 candidate reference genes exhibited a wide range of expression levels: RNA18S (Ct = 9.73 ± 1) had the highest expression and YWHAZ (Ct = 31.88 ± 1.24) had the lowest expression (Fig 3A). For each reference gene, all Ct values showed that any outliers passed the Grubb’s test; thus, no sample was excluded from further analyses. Finally, pairwise comparison between all samples under investigation (all passages analysed) showed a distribution with a correlation coefficient ≥0.96, indicating high expression similarity (Fig 3B).

Fig 2. Validation of primer quality.

Fig 2

(A) RT-qPCR products amplified with each pair of primers revealed a single product of the expected size, while the negative control did not result in any PCR product. (B) Melting curves of each pair of primers show individual dissociation at temperatures > 75°C for all products.

Fig 3. Gene expression stability and pairwise correlation for reference genes.

Fig 3

(A) Expression data are displayed as Ct values for each reference gene in all samples. The line across the box depicts the median. The box indicates the 25th and 75th percentiles. Bars represent the maximum and minimum values. (B) Pairwise correlation analysis for each sample with all reference genes. The histograms show the median distribution of gene expression in each sample. Scatter plots show the distribution of all gene expression for each pair of samples (P0 vs P2, P0 vs P5, P0 vs P7, P0 vs P10, P2 vs P5, P2 vs P7, P2 vs P10, P5 vs P7, P5 vs P10, P7 vs P10) with the regression line and its R2 value ≥ 0.96. (C) Expression data are displayed as Ct values for each reference gene in each sample considered. The line across the box depicts the median.

Determination of HKG expression stability

With the aim of defining the most stable reference genes, the expression stability of the selected HKGs was determined considering all selected passages (Fig 3C). The Mann–Whitney test was performed for each reference gene. The results indicated that B2M (P0 vs P5), ACTB (P0 vs P5 and P2 vs P5), GAPDH (P0 vs P7), GUSB (P2 vs P7), YWHAZ (P2 vs P10), PPIA (P2 vs P10 and P7 vs P10) had a significantly different expression (P < 0.05) (Table 1). Moreover, a low intragroup variability in our HKGs expression (Coefficient of variation (CV) < 5%) was observed with the exception of ACTB (CV < 10%) and RNA18S (CV < 15%) confirming the stability of selected HKGs (S3 Table).

Table 1. Ct values of candidate HKGs in pancreatic tissue, early-passage hPOs and late-passage hPOs after spike-in normalization.

YWHAZ RPL13A PPIA B2M GAPDH TBP ACTB 18S GUSB EF1a UBC HPRT
P0 vs P2 mean 32,14 21,42 22,78 20,75 19,65 31,99 23,01 10,03 27,93 18,88 23,87 25,87
st. dev. 1,06 0,65 0,46 1,06 0,74 0,80 0,34 1,32 0,78 0,75 0,56 0,67
pvalue 0,168 0,924 0,644 0,027 0,217 0,226 0,573 0,108 0,192 0,989 0,103 0,930
p0 vs P5 mean 32,01 21,61 22,42 20,75 19,52 31,67 22,10 10,30 27,64 19,45 24,37 26,02
st. dev. 1,05 0,58 0,86 1,09 0,82 0,72 1,03 0,72 0,63 0,77 1,07 0,43
pvalue 0,313 0,658 0,374 0,088 0,213 0,682 0,038 0,068 0,461 0,151 0,230 0,637
p0 vs P7 mean 31,49 21,56 22,80 20,61 19,67 31,68 22,12 9,98 27,85 19,04 23,60 25,81
st. dev. 1,16 0,46 0,43 1,20 0,72 0,80 1,13 1,25 0,72 0,91 0,72 0,77
pvalue 0,967 0,229 0,739 0,306 0,027 0,649 0,070 0,089 0,255 0,753 0,749 0,837
p0 vs P10 mean 31,34 21,15 22,16 20,41 19,63 31,12 21,86 10,32 27,46 19,29 24,06 25,65
st. dev. 0,90 0,84 0,96 0,98 1,01 1,21 1,33 0,82 1,08 0,98 0,86 0,79
pvalue 0,573 0,379 0,091 0,146 0,308 0,457 0,068 0,248 0,957 0,197 0,481 0,413
P2 vs P5 mean 32,63 21,59 22,35 21,57 19,07 32,17 22,19 9,46 28,14 19,44 24,48 26,00
st. dev. 1,07 0,81 0,91 0,62 0,54 0,87 1,11 0,92 0,81 0,93 0,99 0,74
pvalue 0,863 0,732 0,560 0,995 0,653 0,569 0,021 0,555 0,597 0,291 0,331 0,757
P2 vs P7 mean 32,11 21,54 22,73 21,43 19,22 32,18 22,21 9,13 28,35 19,03 23,72 25,79
st. dev. 1,48 0,73 0,59 0,95 0,55 0,93 1,21 1,12 0,73 1,04 0,75 0,97
pvalue 0,205 0,499 0,718 0,746 0,928 0,092 0,133 0,778 0,032 0,656 0,569 0,664
P2 vs P10 mean 31,97 21,13 22,08 21,22 19,18 31,62 21,96 9,48 27,96 19,28 24,18 25,62
st. dev. 1,36 1,00 0,98 0,91 0,88 1,54 1,42 1,03 1,29 1,10 0,81 0,98
pvalue 0,027 0,128 0,043 0,145 0,944 0,174 0,088 0,669 0,247 0,078 0,608 0,436
P5 vs P7 mean 31,98 21,73 22,37 21,43 19,09 31,87 21,29 9,41 28,06 19,60 24,21 25,94
st. dev. 1,47 0,62 0,90 0,98 0,54 0,94 0,80 0,78 0,79 0,95 1,26 0,84
pvalue 0,605 0,907 0,519 0,842 0,688 0,989 0,963 0,403 0,697 0,464 0,304 0,697
P5 vs P10 mean 31,84 21,32 21,72 21,22 19,05 31,30 21,04 9,75 27,66 19,85 24,67 25,77
st. dev. 1,34 1,02 0,94 0,94 0,87 1,40 0,80 0,44 1,21 0,83 1,06 0,89
pvalue 0,399 0,465 0,664 0,533 0,823 0,549 0,650 0,932 0,820 0,759 0,682 0,510
P7 vs P10 mean 31,32 21,27 22,10 21,08 19,20 31,31 21,06 9,43 27,88 19,44 23,91 25,56
st. dev. 1,35 0,94 0,99 1,13 0,88 1,45 0,95 0,90 1,26 1,15 1,03 1,03
pvalue 0,793 0,266 0,020 0,699 0,906 0,284 0,395 0,560 0,318 0,618 0,240 0,667

(P ≤ 0.05 is highlighted in yellow).

The stability ranking for each category was evaluated using four different statistical analyses, NormFinde, geNorm, BestKeeper and ΔCt method, as reported in Table 2. Moreover, since we used various approaches showing differences in the HKG stability, a comprehensive final ranking of the most stable reference genes, based on the geometric mean (geo.mean) of each gene weight generated by the four methods, was obtained using the RefFinder tool. Considering all the passages analysed the best housekeeping gene to normalize a RT-qPCR study on human pancreatic organoids were RPL13A (geo.mean = 1.19), and HPRT (geo.mean = 1.73) whereas the least stable HKG were RNA18S (geo.mean = 10.49) and ACTB (geo.mean = 11.24) (Fig 4).

Table 2. Gene expression stability rankings of the twelve reference genes calculated by NormFinder, geNorm, BestKeeper, ΔCt and RefFinder.

Sample Gene NormFinder geNorm BestKeeper Δes RefFinder
Stability value M value ST.DEV ST.DEV Value Rank
Human Panctreatic Organoids (Passages from 0 to 10) ACTB 0,684 0,89 0,95 1,28 11,24 12
B2M 0,435 0,69 0,83 0,91 6,59 8
EF1a 0,506 0,67 0,78 0,92 6,24 7
GAPDH 0,380 0,69 0,64 0,93 4,23 4
GUSB 0,334 0,63 0,80 0,78 3,46 3
HPRT 0,210 0,65 0,67 0,73 1,73 2
PPIA 0,416 0,72 0,68 0,88 5,69 5
RNA18S 0,711 1,28 0,79 1,50 10,49 11
RPL13A 0,247 0,61 0,62 0,73 1,19 1
TBP 0,403 0,72 0,90 0,85 6,12 6
UBC 0,515 0,73 0,67 0,98 7,21 9
YWHAZ 0,493 0,81 0,94 0,95 9,43 10

Fig 4. Final stability ranking of the twelve reference genes as calculated by RefFinder.

Fig 4

The comprehensive final ranking for all samples pooled together was obtained using the RefFinder tool based on the geometric mean of the geNorm, NormFinder, BestKeeper and ΔCt method values.

Impact of HKGs on the expression levels of selected genes

To further evaluate the impact and reliability of the selected reference genes, RT-qPCR analysis was conducted on two specific marker genes for epithelial ductal cells (EpCAM and SOX9), which represent the most enriched cell population in hPO culture. Next, the expression levels were normalized using both the most (RPL13A), the least (ACTB) stable HKGs and exogenous RNA (ERCC RNA Spike-In) as alternative normalization approach, due to their quality and quantity is known [2123]. Moreover, to avoid possible errors related to the use of only one HKG [11], we also normalized the results using the geo.mean of the Ct value of the two best reference genes identified by NormFinder (PPIA and UBC). Finally, we performed the gene expression normalization using GAPDH, the widely used HKG in the literature. After data normalization, we evaluated the modulation of gene expression using hPO P0 as a reference (Fig 5). We observed a stable expression of EpCAM and SOX9 only when our selected HKG (RPL13A) and the geo.mean were used, on the other hand, using ERCC RNA Spike-In or GAPDH to perform the normalization, instability in the expression of the selected ductal genes was observed, and this is in contrast with the protein levels detected in our hPOs (S1 Fig). Moreover, focusing on the less stable HKG (ACTB) an apparent reduction of EpCAM and SOX9 expression was noticed, this behaviour was also in contrast with the detected protein levels (S1 Fig). Taken together, these results demonstrate that the selection and the number of appropriate HKGs to be used are critical parameters to avoid false results and to obtain reliable and significant data by gene expression analysis.

Fig 5. Reliability of selected housekeeping genes.

Fig 5

The relative transcriptional level of the two ductal markers EpCAM and SOX9 in each sample condition considered was normalized with the best and the worst reference gene (RPL13A and ACTB, respectively), the geometric mean (Geo.mean) of two selected HKGs by NormFinder (PPIA and UBC) and one commonly used gene (GAPDH). One-way analysis of variance followed by Dunnett’s post-hoc test for multiple comparisons was used.

Discussion

Three-dimensional organoid culture systems have emerged as a powerful tool to accurately recapitulate adult stem cell maintenance, differentiation and disease pathophysiology for various organs, including the brain, intestine, liver, pancreas and kidney [2428]. Recently, our group has described and presented hPOs as a potential source of functional cells for the treatment of type 1 diabetes as they are able to be expanded and cryopreserved without morphological or molecular changes until passage 5 [9]. There is no doubt that organoids have opened remarkable opportunities very rapidly in many fields; however, to envision their use in research and in clinical contexts, from drug efficacy to organ replacement function, human organoids must be fully and extensively characterized. Due to its low cost and ease of operation, RT-qPCR is consistently used as a first step to assess the expression levels of tissue-specific genes [29, 30]. Indeed, gene expression quantification is widely considered the best method to confirm or confute the identity of any type of cell or tissue, including the emerging human organoids. The main drawbacks for this “gold standard” method are the imprecision and the high number of technical errors that could affect the reproducibility and the accuracy of the results generated using this technique [11].

To start the molecular characterization, some crucial aspects must be kept in mind. The first one is the appropriate choice of the reference genes to correct for errors in sample quantification as well as sample-to-sample differences in the efficiency of reverse transcription and PCR amplification [31]. The use of non-validated reference genes can lead to erroneous and inconsistent results, which are biologically meaningless. Therefore, it is important that the expression level of the selected HKG is stable and unaffected by the experimental conditions used in the analysis.

Recently, numerous studies focusing on this critical aspect [32, 33] have been presented in the literature, but not even one refers to the human organoid context. Indeed, to the best of our knowledge, there are no previous reports regarding the validation of reference genes for gene expression assays of hPOs. In the current work, we present the first study on hPOs focusing on the identification and validation of a suitable set of HKGs to use in gene expression analysis during short- and long-term culture. To select the best reference gene for hPO transcriptional analysis, we performed a comparison of 12 commonly used HKGs belonging to 5 different functional families: metabolism/cell viability-related genes (GAPDH, HPRT and YWHAZ); a structure/cytoskeleton-related gene (ACTB); protein folding and modification-related genes (GUSB, PPIA and UBC); transcription/translation-related genes (EF1A, RNA18S, RPL13A and TBP); and an antigen processing-related gene (B2M). In order to identify the most suitable reference gene, we analysed the expression data using four independent statistical algorithms previously reported: BestKeeper, NormFinder, geNorm and the comparative ΔCt method. All these algorithms gave consistent results, although the most stable genes were not listed in the same order. Next, to provide a comprehensive ranking of the HKGs, we combined all of the data obtained with the four algorithms using the tool RefFinder [34]. This approach can produce precise results by integrating and balancing all of the features of the mentioned methods [13].

To evaluate the transcription levels of the selected HKGs, we first performed a preliminary validation of our primers. Our results showed no dimer formation and an appreciable efficiency (efficiency = 95–105%) combined with an acceptable level of expression (Ct < 35). Altogether, these parameters should be underlined because they play a key role for the validity of this type of study [11].

Based on our statistical analysis, we found the most stable gene to use alone or in combination for normalization of RT-qPCR analysis of hPO isolation and maintenance in culture. Interestingly, to characterize the long-term hPO culture by gene expression analysis, we observed that the most stable HKG was RPL13A, while NormFinder suggested PPIA-UBC as the best couple genes to perform data normalization. This result was in accordance with previous work showing that the mRNA expression levels of RPL13A was stable in a variety of human tissues, including pancreatic cells, making it an excellent reference genes [3537]. On the other hand, ACTB and RNA18S, two of the most-used reference genes, appeared to be less reliable. This is not surprising, since there are many documented reports showing that the mRNA levels of ACTB and RNA18S fluctuate [38]. However, they are still commonly used as reference genes.

Furthermore, our analysis showed that the intragroup and intergroup comparisons could influence the choice of the HKG to be used. Therefore, it is evident that the identification of a stable reference gene for accurate and reproducible RT-qPCR data normalization remains a critical task, particularly when performing gene expression profile analysis using samples from different individuals.

Conclusion

The present study is the first report of a systemic evaluation of potential HKGs suitable for accurate RT-qPCR normalization of hPOs as well as comparative studies with pancreatic tissue. The HKGs were ranked according to their stability in different experimental setups. This work provides a solid basis for future gene expression analysis in the hPO field and can be taken as an example to generally expand the knowledge of this three-dimensional culture system as well as to act as a guide for future studies.

Supporting information

S1 Fig. Flow cytometry analysis of human pancreatic organoids.

(TIF)

S1 Table. Candidate HKGs.

(DOCX)

S2 Table. Primer sequences, amplicon length and primer efficiencies.

(DOCX)

S3 Table. Coefficient of variation of selected HKGs.

(DOCX)

S1 File. Sanger sequencing and uncropped gel images.

(ZIP)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was funded by the grant “LSFM4LIFE-Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes” project number 668350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Shamir E. R. & Ewald A. J. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol 15, 647–664, doi: 10.1038/nrm3873 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dutta D., Heo I. & Clevers H. Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends Mol Med 23, 393–410, doi: 10.1016/j.molmed.2017.02.007 (2017). [DOI] [PubMed] [Google Scholar]
  • 3.Nakamura T. & Sato T. Advancing Intestinal Organoid Technology Toward Regenerative Medicine. Cell Mol Gastroenterol Hepatol 5, 51–60, doi: 10.1016/j.jcmgh.2017.10.006 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Broutier L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med 23, 1424–1435, doi: 10.1038/nm.4438 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pradhan S. et al. Tissue Responses to Shiga Toxin in Human Intestinal Organoids. Cell Mol Gastroenterol Hepatol, doi: 10.1016/j.jcmgh.2020.02.006 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Benito-Kwiecinski S. & Lancaster M. A. Brain Organoids: Human Neurodevelopment in a Dish. Cold Spring Harb Perspect Biol, doi: 10.1101/cshperspect.a035709 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Low J. H. et al. Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Cell Stem Cell 25, 373–387 e379, doi: 10.1016/j.stem.2019.06.009 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mellin R. & Boddey J. A. Organoids for Liver Stage Malaria Research. Trends Parasitol 36, 158–169, doi: 10.1016/j.pt.2019.12.003 (2020). [DOI] [PubMed] [Google Scholar]
  • 9.Dossena M. et al. Standardized GMP-compliant scalable production of human pancreas organoids. Stem Cell Res Ther 11, 94, doi: 10.1186/s13287-020-1585-2 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Georgakopoulos N. et al. Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoids. BMC developmental biology 20, 4, doi: 10.1186/s12861-020-0209-5 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bustin S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611–622, doi: 10.1373/clinchem.2008.112797 (2009). [DOI] [PubMed] [Google Scholar]
  • 12.Bustin S. A. et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 11, 74, doi: 10.1186/1471-2199-11-74 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ragni E., Perucca Orfei C., Bowles A. C., de Girolamo L. & Correa D. Reliable Reference Genes for Gene Expression Assessment in Tendon-Derived Cells under Inflammatory and Pro-Fibrotic/Healing Stimuli. Cells 8, doi: 10.3390/cells8101188 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kozera B. & Rapacz M. Reference genes in real-time PCR. J Appl Genet 54, 391–406, doi: 10.1007/s13353-013-0173-x (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Silver N., Best S., Jiang J. & Thein S. L. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol 7, 33, doi: 10.1186/1471-2199-7-33 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Vandesompele J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034, doi: 10.1186/gb-2002-3-7-research0034 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Andersen C. L., Jensen J. L. & Orntoft T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64, 5245–5250, doi: 10.1158/0008-5472.CAN-04-0496 (2004). [DOI] [PubMed] [Google Scholar]
  • 18.Pfaffl M. W., Tichopad A., Prgomet C. & Neuvians T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper—Excel-based tool using pair-wise correlations. Biotechnol Lett 26, 509–515, doi: 10.1023/b:bile.0000019559.84305.47 (2004). [DOI] [PubMed] [Google Scholar]
  • 19.Xiao X. et al. PNA lectin for purifying mouse acinar cells from the inflamed pancreas. Sci Rep 6, 21127, doi: 10.1038/srep21127 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu J. et al. TGF-beta1 promotes acinar to ductal metaplasia of human pancreatic acinar cells. Sci Rep 6, 30904, doi: 10.1038/srep30904 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lun A. T. L., Calero-Nieto F. J., Haim-Vilmovsky L., Gottgens B. & Marioni J. C. Assessing the reliability of spike-in normalization for analyses of single-cell RNA sequencing data. Genome Res 27, 1795–1806, doi: 10.1101/gr.222877.117 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stegle O., Teichmann S. A. & Marioni J. C. Computational and analytical challenges in single-cell transcriptomics. Nat Rev Genet 16, 133–145, doi: 10.1038/nrg3833 (2015). [DOI] [PubMed] [Google Scholar]
  • 23.Bacher R. & Kendziorski C. Design and computational analysis of single-cell RNA-sequencing experiments. Genome Biol 17, 63, doi: 10.1186/s13059-016-0927-y (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lancaster M. A. & Knoblich J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125, doi: 10.1126/science.1247125 (2014). [DOI] [PubMed] [Google Scholar]
  • 25.Sato T. & Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190–1194, doi: 10.1126/science.1234852 (2013). [DOI] [PubMed] [Google Scholar]
  • 26.Huch M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299–312, doi: 10.1016/j.cell.2014.11.050 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Boj S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338, doi: 10.1016/j.cell.2014.12.021 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Takasato M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568, doi: 10.1038/nature15695 (2015). [DOI] [PubMed] [Google Scholar]
  • 29.Bustin S. A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29, 23–39, doi: 10.1677/jme.0.0290023 (2002). [DOI] [PubMed] [Google Scholar]
  • 30.Ginzinger D. G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30, 503–512, doi: 10.1016/s0301-472x(02)00806-8 (2002). [DOI] [PubMed] [Google Scholar]
  • 31.Turabelidze A., Guo S. & DiPietro L. A. Importance of housekeeping gene selection for accurate reverse transcription-quantitative polymerase chain reaction in a wound healing model. Wound Repair Regen 18, 460–466, doi: 10.1111/j.1524-475X.2010.00611.x (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.McLoughlin K. J., Pedrini E., MacMahon M., Guduric-Fuchs J. & Medina R. J. Selection of a Real-Time PCR Housekeeping Gene Panel in Human Endothelial Colony Forming Cells for Cellular Senescence Studies. Front Med (Lausanne) 6, 33, doi: 10.3389/fmed.2019.00033 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kloubert V. & Rink L. Selection of an inadequate housekeeping gene leads to misinterpretation of target gene expression in zinc deficiency and zinc supplementation models. J Trace Elem Med Biol 56, 192–197, doi: 10.1016/j.jtemb.2019.08.007 (2019). [DOI] [PubMed] [Google Scholar]
  • 34.Xie F., Xiao P., Chen D., Xu L. & Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol, doi: 10.1007/s11103-012-9885-2 (2012). [DOI] [PubMed] [Google Scholar]
  • 35.Yan Z. et al. Quantitative Evaluation and Selection of Reference Genes for Quantitative RT-PCR in Mouse Acute Pancreatitis. Biomed Res Int 2016, 8367063, doi: 10.1155/2016/8367063 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jesnowski R., Backhaus C., Ringel J. & Lohr M. Ribosomal highly basic 23-kDa protein as a reliable standard for gene expression analysis. Pancreatology 2, 421–424, doi: 10.1159/000065091 (2002). [DOI] [PubMed] [Google Scholar]
  • 37.Curtis K. M. et al. EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol 11, 61, doi: 10.1186/1471-2199-11-61 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tong Z., Gao Z., Wang F., Zhou J. & Zhang Z. Selection of reliable reference genes for gene expression studies in peach using real-time PCR. BMC Mol Biol 10, 71, doi: 10.1186/1471-2199-10-71 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Zoltán Rakonczay Jr

6 Sep 2021

PONE-D-21-24295Human pancreatic organoids: correct choice of housekeeping gene leads to accurate and reproducible gene expression profile analysisPLOS ONE

Dear Dr. Lazzari,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your paper has been reviewed by two experts in the field, both of whom had found merit in your study. To improve the paper, early and late time points need to be clarified. Also note that the use of islet-depleted pancreatic tissue to compare changes of housekeeping genes in early and late organoids is somewhat misleading since the pancreatic tissue consists mostly of acinar cells, whereas organoids are almost exclusively ductal cells. 

Please submit your revised manuscript by Oct 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Zoltán Rakonczay Jr., M.D., Ph.D., D.Sc.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please amend your current ethics statement to address the following concerns:

a) Did participants provide their written or verbal informed consent to participate in this study?

b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure.

3. Thank you for stating the following financial disclosure: 

 [This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]  

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

[hPOs were generated starting from adult healthy islet-depleted pancreatic tissue gently provided by the Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

 [This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. 

  

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

7. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this report, Alessandro Cherubini and colleagues present data on gene expression changes occurring during pancreas related organoid culture maturation. These results are potentially quite interesting, and it has strong scientific value which can be applied to identify the most reliable control for gene expression studies. However, they well-performed experiments to try to answer these specific questions, my feeling is that two time point limiting the evaluation of their result so i recommend additional time points to extend their study. My feeling is that although it is an interesting study with a valuable scientific background, the presented results must be supplemented with additional measurements:

The authors use an early and a late time point to measure gene expression of several housekeeping gene. I would strongly recommend including to the study the original primary cell which they used to create the organoid culture. Additionally, i also strongly suggest adding 2-3 time points between the early and late stage to prove that the development of the organoid does not affect significantly the expression of the selected genes.

Finally, i also strongly recommend changing the title form a general one to more specific-

Based on these i recommend major revision of the current study before publication.

Reviewer #2: Cherubini et al. analysed the expression of housekeeping genes in human pancreatic organoids. This is an important contribution as 3D organoid culture is an emerging technology that is utilized in a rapidly increasing number of studies. The paper is well executed and the results are analysed correctly.

Major comment:

1. The authors used the islet-depleted pancreatic tissue to compare changes of HKGs in early and late organoids. This is somewhat misleading, as the pancreatic tissue consist mostly of acinar cells, whereas organoids are almost exclusively ductal cells. Therefore comparing isolated ductal fragments with organoids seems to be more relevant.

2. How was "early' and "late" passages defined? The early passage in my point of view would be passage No. 2. In the fifth passage the organoids were grown in vitro for several weeks, which may impact gene expression. Therefore I recommend adding passage No.2. to the anaylsis as well.

MInor point:

1. The "early" and "late" organoids are described in section two in the Results, however it is already used in Figure 1.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: József Maléth

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Dec 8;16(12):e0260902. doi: 10.1371/journal.pone.0260902.r002

Author response to Decision Letter 0


20 Oct 2021

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We formatted our manuscript following the PLOS ONE's style requirements.

2. Please amend your current ethics statement to address the following concerns:

a) Did participants provide their written or verbal informed consent to participate in this study?

b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure.

Human pancreata were obtained from the Pancreatic Islet Processing Unit of the Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy, in the context of transplantation organ, after approval of the Institutional Review Board (National Transplant Center accredited facility IT000679). Therefore, the fresh tissue was obtained from organ donors. The use of human specimens was approved by the Ethical Committee of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico n° 1982, 14th January 2020.

3. Thank you for stating the following financial disclosure:

[This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, we added the appropriate sentences as suggested.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

[hPOs were generated starting from adult healthy islet-depleted pancreatic tissue gently provided by the Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

[This work was funded by the grant “LSFM4LIFE–Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of Type 1 diabetes”, project number 668350.]

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

We included the acknowledgment section in cover letter as suggested.

5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

We generated a supporting information that contains all uncropped gels underline the picture used in our manuscript and related to Figure 2.

6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

We added the ORCID ID of all the authors into the cover letter.

7. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

We removed the sentence “data not shown” and we generated a supporting information containing all the sequences used in our manuscript.

8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

We added captions related to our supporting information at the end of the paper after Reference section as reported here:

Supporting information

Fig. S1 Flow cytometry analysis of human pancreatic organoids.

Table S1 Candidate HKGs.

Table S2 Primer sequences, amplicon length and primer efficiencies.

Table S3 Coefficient of variation of selected HKGs.

Supporting information file Sanger sequencing and uncropped gel images.

Reviewer #1: In this report, Alessandro Cherubini and colleagues present data on gene expression changes occurring during pancreas related organoid culture maturation. These results are potentially quite interesting, and it has strong scientific value which can be applied to identify the most reliable control for gene expression studies. However, they well-performed experiments to try to answer these specific questions, my feeling is that two time point limiting the evaluation of their result so I recommend additional time points to extend their study. My feeling is that although it is an interesting study with a valuable scientific background, the presented results must be supplemented with additional measurements:

The authors use an early and a late time point to measure gene expression of several housekeeping gene. I would strongly recommend including to the study the original primary cell which they used to create the organoid culture. Additionally, I also strongly suggest adding 2-3 time points between the early and late stage to prove that the development of the organoid does not affect significantly the expression of the selected genes.

We thank Reviewer#1 for these comments. Following his/her indication we added the results obtained using the original primary cells from which we generated our hPOs (named P0 in our revised manuscript) after removing the islet-depleted tissue. The pancreatic tissue mainly consists of acinar cells, whereas organoids are almost exclusively composed by ductal cells and this could be considered misleading. Furthermore, to reinforce our analysis we added other time points (P0, P2, P7), and now the gap between two time points is no longer than three passages, we made it to avoid the effect of the development of hPOs on the expression of our selected genes.

Finally, I also strongly recommend changing the title form a general one to more specific-one

We are grateful for this recommendation. The new title that we proposed is: “Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.”.

Based on these I recommend major revision of the current study before publication.

Reviewer #2: Cherubini et al. analysed the expression of housekeeping genes in human pancreatic organoids. This is an important contribution as 3D organoid culture is an emerging technology that is utilized in a rapidly increasing number of studies. The paper is well executed and the results are analysed correctly.

Major comment:

1. The authors used the islet-depleted pancreatic tissue to compare changes of HKGs in early and late organoids. This is somewhat misleading, as the pancreatic tissue consist mostly of acinar cells, whereas organoids are almost exclusively ductal cells. Therefore comparing isolated ductal fragments with organoids seems to be more relevant.

We thank Reviewer#2 for these comments. Following his/her advice we decided to remove the islet-depleted pancreatic tissue from our analysis, and we replaced it with the hPO passage 0 (P0) because it is enriched of ductal fragments from which organoids are derived as suggested in our previously published paper: “Standardized GMP-compliant scalable production of human pancreas organoids”, Dossena et al., 2020 DOI: 10.1186/s13287-020-1585-2.

2. How was "early' and "late" passages defined? The early passage in my point of view would be passage No. 2. In the fifth passage the organoids were grown in vitro for several weeks, which may impact gene expression. Therefore I recommend adding passage No.2. to the anaylsis as well.

We are grateful for these comments that improved our manuscript. Since human pancreatic organoids could be expanded for several months, we considered at “early passage” hPO at P5 (< 2 months), and at “late passage” the hPO cultured for more than P5 (> 2 months). We reported the description of early and late passages in the caption of Figure 1.

We totally agree with Reviewer#2 that hPO at P2 are the best representation of an “early passage”, therefore we included in our study also the hPO at P2. Moreover, to exclude that the development of the organoid did affect significantly the expression of our selected genes we added other passages. In the present form, different time points (P0, P2, P5, P7, P10) are presented, therefore now the gap between the two time points is no longer than three passages.

Minor point:

1. The "early" and "late" organoids are described in section two in the Results, however it is already used in Figure 1.

We added the definition of “early” and “late” passage in the main text, Figure 1 caption (lines 159-163 revised manuscript and lines 154-158 manuscript).

Attachment

Submitted filename: Rebuttal Letter_Cherubini et al.doc

Decision Letter 1

Zoltán Rakonczay Jr

19 Nov 2021

Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.

PONE-D-21-24295R1

Dear Dr. Lazzari,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Zoltán Rakonczay Jr., M.D., Ph.D., D.Sc.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors answered all of my question, therefore i recommend it for accptance and publication at PLOS One.

Reviewer #2: The authors properly addressed my comments and included the requested additional analysis to the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tibor Pankotai

Reviewer #2: Yes: József Maléth

Acceptance letter

Zoltán Rakonczay Jr

24 Nov 2021

PONE-D-21-24295R1

Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.

Dear Dr. Lazzari:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Zoltán Rakonczay Jr.

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Flow cytometry analysis of human pancreatic organoids.

    (TIF)

    S1 Table. Candidate HKGs.

    (DOCX)

    S2 Table. Primer sequences, amplicon length and primer efficiencies.

    (DOCX)

    S3 Table. Coefficient of variation of selected HKGs.

    (DOCX)

    S1 File. Sanger sequencing and uncropped gel images.

    (ZIP)

    Attachment

    Submitted filename: Rebuttal Letter_Cherubini et al.doc

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES